Best Hospitals, U.S. News and World Report, National Ranked in 13 specialties - 2014-15

Duke University Hospital: consistently ranked among the nation's best.

AHA Conference Coverage

November 14-17, 2016 | by Lori Alexander

Early ambulation may benefit patients with HF

November 14, 2016

Hospitals with the highest rates of early ambulation had the shortest lengths of stay after stratification. [Read more]

Use of mineralocorticoids associated with decreased risk of rehospitalization at 1 and 3 years

November 14, 2016

Mineralocorticoid receptor antagonists may be safe and beneficial for use in certain patients with HF and other comorbidities.
[Read more]

Ticagrelor not superior to clopidogrel for reducing cardiovascular events

November 14, 2016

Duke researcher says these results demonstrate the hazards of extrapolating evidence from coronary artery disease populations to PAD. [Read more]

Extended-duration betrixaban reduces symptomatic VTE in select hospitalized patients

November 15, 2016

Easing the total burden of VTE among patients taking betrixaban could free up health care resources and help alleviate costs. [Read more]

Rivaroxaban reduces risk of bleeding in patients with AF undergoing PCI with stenting

November 15, 2016

A rivaroxaban-based strategy reduced the risk of clinically significant bleeding compared with warfarin-based treatment. [Read more]

Study identifies characteristics of FH in children and adolescents

November 15, 2016

Nearly one-third of youth with FH have a family history of premature myocardial infarction. [Read more]

Apo-A1 is well tolerated and may be safe in patients after recent MI

November 16, 2016

Apo-A1 has the potential to reduce major adverse cardiovascular events. [Read more]

Format of risk communications influences perceived risk and willingness for therapy

November 16, 2016

Communicating lifetime rather than short-term risk estimates has a greater influence on how patients perceive their risk of CVD. [Read more]

Cause-specific mortality among patients taking anticoagulation for AF

November 16, 2016

Sudden cardiac death and HF are the most common cardiovascular-related deaths in patients with AF taking an oral anticoagulant. [Read more]

Extended-duration betrixaban reduces stroke in medically ill hospitalized patients

November 17, 2016

Betrixaban significantly reduced the rate of any stroke compared with thromboprophylactic enoxaparin. [Read more]

Routine use of high-dose spironolactone not beneficial in acute HF

November 17, 2016

Although study findings do not support the routine use of spironolactone, patients with a higher ejection fraction may gain some benefit. [Read more]

Oral iron supplementation does not improve functional capacity in chronic HF

November 17, 2016

Although oral supplementation with iron is safe and readily available, study results suggest that it does not improve functional capacity in patients with HF and reduced ejection fraction. [Read more]